IONIS PHARMACEUT reported $3M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Astellas Pharma 4503:JP Y 62505M 274M
Biocryst Pharmaceuticals BCRX:US $ 0.62M 0.27M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Bluebird Bio BLUE:US $ 19.7M 4.4M
Esperion Therapeutics ESPR:US $ 5.56M 3.76M
Exelixis EXEL:US $ 11.87M 3.01M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Halozyme Therapeutics HALO:US $ 18.59M 4.43M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Moderna Inc MRNA:US 722M 28M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Novartis NOVN:VX SF 3848M 94M
Omeros OMER:US $ 333K 9K
Pfizer PFE:US $ 9931M 2939M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Ultragenyx Pharmaceutical RARE:US $ 4.18M 1.04M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M